How Structured Protocol Authoring Reduces Protocol Amendment Rework
A closer look at how governed clinical content reduces duplicated edits, downstream misalignment, and amendment review burden across the protocol
ePI and FHIR: A Practitioner’s Walkthrough of the FHIR ePI Implementation Guide
What Pharma Companies Need to Know About ePI FHIR When the European medicines regulatory network adopted the EU ePI Common
ePI vs SPL: Preparing for EU Electronic Product Information and FDA Structured Product Labeling
How EU ePI and FDA SPL Create Parallel Labeling Workflows A director of Regulatory Affairs at a mid-sized pharma company
When EMA Says Go: What the ePI Mandate Actually Requires From Your Content Operations
EMA ePI requirements are moving from roadmap item to operational mandate. This article explains what the shift means for labeling, regulatory, and CMC content operations.
Clinical Documentation Guide
This paper explains how escalating trial complexity, regulatory scrutiny, and interoperability demands have made traditional document-based clinical documentation unsustainable.
Structured Content for Clinical Documents: The Future of Regulatory Writing
The Challenge: Fragmented Authoring and Redundant Writing in Clinical Operations For decades, clinical documentation has been both the foundation and
AI in Regulatory Affairs: Cutting Through the Hype
How governed, structured content enables responsible AI in life sciences. Artificial intelligence (AI) has moved from a buzzword to a
Understanding Data Interoperability in Pharma: Key Concepts and Best Practices
Breaking Down Silos: Pharma’s Interoperability Imperative Pharma’s digital transformation has is modernizing labeling, digitized document management, and integrated Regulatory Information
Enhancing The Patient Experience with ePI
ePI is reshaping pharma’s digital future. Learn how structured content and AI help life sciences companies meet compliance faster, with accuracy, agility, and scale.
7 Real-World Use Cases for AI-Powered Structured Content Authoring in Pharma
Discover how AI-powered structured content authoring transforms pharma documentation — from labeling and safety narratives to CTD module alignment and metadata tagging.
A Primer on the Structured Content Landscape: Why the Future of Pharma Depends on Structured Content in Life Sciences
Explore how structured content transforms life-sciences: driving reuse, traceability, regulatory readiness, and faster time-to-market in pharma. Includes download.